# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### Definitions

## EXAMPLES

### Example 1—PHASE I, Open-Label Safety and Delivery Optimization Study of an Autologous Neo-Kidney Augment (NKA) in Patients with Chronic Kidney Disease (TNG-CL010)

### Example 2—PHASE II, Open-Label Safety and Efficacy Study of an Autologous Neo-Kidney Augment (NKA) in Patients with Type 2 Diabetes and Chronic Kidney Disease (RMCL-001)

### Example 3—NKA Injection for Interventional Radiology

### Example 4—A Phase II, Open-Label Safety and Tolerability Study of an Autologous Neo-Kidney Augment (NKA) in Patients with Type 2 Diabetes and Chronic Kidney Disease (RMCL-002 and RMCL-003)

